CNXU (Conexeu Sciences) Net Margin %: 0.00% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNXU Conexeu Sciences Inc CNXU
12 GF Score
Price $7.25
! 1 Warning Sign
View Full Analysis

What is Conexeu Sciences Net Margin %?

Conexeu Sciences CNXU -9.91% 12 Net Margin % is 0.00% as of Apr. 2026. GuruFocus rates CNXU with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, Conexeu Sciences ranks worse than 105932.1% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Conexeu Sciences's Net Income for the three months ended in Apr. 2026 was $-2.30 Mil. Conexeu Sciences's Revenue for the three months ended in Apr. 2026 was $0.00 Mil. Therefore, Conexeu Sciences's net margin for the quarter that ended in Apr. 2026 was 0.00%.

The historical rank and industry rank for Conexeu Sciences's Net Margin % or its related term are showing as below:


CNXU's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.875
* Ranked among companies with meaningful Net Margin % only.

Conexeu Sciences  (NAS:CNXU) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Conexeu Sciences Net Margin % Related Terms

Conexeu Sciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Conexeu Sciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conexeu Sciences Net Margin % Chart

Conexeu Sciences Annual Data
Trend Oct24 Oct25
Net Margin %
0.00 0.00

Conexeu Sciences Quarterly Data
Oct24 Jan25 Apr25 Oct25 Jan26 Apr26
Net Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CNXU vs GALT, SRZN, RNAC: Net Margin % Comparison

For the Biotechnology subindustry, Conexeu Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Conexeu Sciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Conexeu Sciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Conexeu Sciences's Net Margin % falls into.


CNXU
12GF Score
Conexeu Sciences Inc CNXU
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conexeu Sciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Conexeu Sciences's Net Margin for the fiscal year that ended in Oct. 2025 is calculated as

Net Margin=Net Income (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-3.924/0
= %

Conexeu Sciences's Net Margin for the quarter that ended in Apr. 2026 is calculated as

Net Margin=Net Income (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-2.304/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Conexeu Sciences (CNXU) has a Net Margin % of 0.00% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Conexeu Sciences and its competitors. According to the industry distribution chart, Conexeu Sciences ranks #999999 out of 944 companies in the Biotechnology industry.
Is Conexeu Sciences' Net Margin % too high?
Conexeu Sciences' current Net Margin % is 0.00%. Based on the distribution chart, Conexeu Sciences ranks #999999 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Conexeu Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Conexeu Sciences' Net Margin % compare to GALT and SRZN?
According to the Biotechnology industry distribution chart, Conexeu Sciences ranks #999999 out of 944 companies for Net Margin %. This places Conexeu Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Conexeu Sciences and its competitors. Conexeu Sciences's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conexeu Sciences stock overvalued right now?
Conexeu Sciences (CNXU) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Conexeu Sciences' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Conexeu Sciences (CNXU), the current Net Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Conexeu Sciences Business Description

Address 50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
12GF Score

Get the complete analysis for CNXU

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.25
Price